Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Pomalidomide Plus Dexamethasone (Pd) in the Treatment of Asian Patients with Relapsed/Refractory Myeloma (RRMM) Who Are Previously Treated with Bortezomib and Refractory to Lenalidomide - Interim Analysis of a Trial By the Asian Myeloma Network (AMN)

Wee J Chng, MD MRCP, FRCPATH, PhD, Kihyun Kim, MD PhD, Jeffrey Huang, Chor Sang Chim, MBChB, Hiroshi Kosugi, MD PhD, Naoki Takezako, MD PhD, Junichi Sakamoto, MD PhD, Sathish Kumar Gopalakrishnan, Yuan Wei, Ling Ying Zhuo, Je-Jung Lee, Sung-Soo Yoon, MD PhD, Jin Seok Kim, MD PhD, Chang-Ki Min, Jae-Hoon Lee, Brian G M Durie

Blood (2016) 128 (22): 2130.

https://doi.org/10.1182/blood.V128.22.2130.2130

Published: 2016

Journal Articles

Paediatric-Inspired Acute Lymphoblastic Leukemia Protocols, Are They Too Toxic for Young Adults?

Melissa G. Ooi, MDMRCP FRCPath PhD, Wee J Chng, MD MRCP, FRCPATH, PhD, Chin-Hin Ng, MD MRCP, FRCPATH, Yi Ching Yuen, MClinPharm, BCOP, BCPS, CGP, Allen Eng Juh Yeoh, MD, Chiew Kean Hui, Elaine Seah, BSc

Blood (2016) 128 (22): 5162.

https://doi.org/10.1182/blood.V128.22.5162.5162

Published: 2016

Journal Articles

“Micro”-managing the MiRNome in SzS

Wee J. Chng

Blood (2010) 116 (7): 1021–1022.

https://doi.org/10.1182/blood-2010-05-285189

Published: 2010

Journal Articles

Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications

Wee J. Chng, Ellen D. Remstein, Rafael Fonseca, P. Leif Bergsagel, Julie A. Vrana, Paul J. Kurtin, Ahmet Dogan

Blood (2009) 113 (3): 635–645.

https://doi.org/10.1182/blood-2008-02-140996

Published: 2009

Includes: Supplemental data

Journal Articles

The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition

Wee J. Chng, Esteban Braggio, George Mulligan, Barbara Bryant, Ellen Remstein, Riccardo Valdez, Ahmet Dogan, Rafael Fonseca

Blood (2008) 111 (3): 1603–1609.

https://doi.org/10.1182/blood-2007-06-097774

Published: 2008

Includes: Supplemental data

Journal Articles

Activation of MYC Pathway Is a Unifying Pathological Event in the Progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma (MM).

Wee J. Chng, MD, Marta Chesi, PhD, Tammy Price-Troska, Greg Ahmann, Kim Henderson, Philip Greipp, MD, Robert Kyle, MD, S. Vincent Rajkumar, MD, Morie Gertz, MD, Rafael Fonseca, MD, P. Leif Bergsagel, MD

Blood (2007) 110 (11): 241.

https://doi.org/10.1182/blood.V110.11.241.241

Published: 2007

Journal Articles

Multiple Myeloma (MM) Is Characterized by Genomic Instability Regardless of Ploidy Categories and Degree of Karyotypic Complexity Is an Important Prognostic Factor.

Wee J. Chng, MD, Jonathan J. Keats, PhD, Esteben Braggio, PhD, Angela Baker, PhD, P. Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2007) 110 (11): 1476.

https://doi.org/10.1182/blood.V110.11.1476.1476

Published: 2007

Journal Articles

Identification of Survival Critical Genomic Gains or Losses in Myeloma (MM) Using Array-Comparative Genomic Hybridization (aCGH).

Wee J. Chng, MD, Tae-Hoon Chung, PhD, Jonathan J. Keats, PhD, Angela Baker, PhD, P. Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2007) 110 (11): 2471.

https://doi.org/10.1182/blood.V110.11.2471.2471

Published: 2007

Journal Articles

Gene Expression Profiling of Pulmonary Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Identifies New Diagnostic Markers, Biological Heterogeneity and Therapeutic Targets.

Wee J. Chng, MD, Rafael Fonseca, MD, Peter Leif Bergsagel, MD, Julia A. Vrana, Paul J. Kurtin, MD, Ellen Remstein, MD, Ahmet Dogan, MD

Blood (2007) 110 (11): 560.

https://doi.org/10.1182/blood.V110.11.560.560

Published: 2007

Journal Articles

Survival of genetic subtypes of relapsed myeloma may be modulated by secondary events

Wee J. Chng, George Mulligan, Barbara Bryant, Leif Bergsagel

Blood (2007) 109 (8): 3610–3611.

https://doi.org/10.1182/blood-2006-09-048769

Published: 2007

Journal Articles

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

George Mulligan, Constantine Mitsiades, Barb Bryant, Fenghuang Zhan, Wee J. Chng, Steven Roels, Erik Koenig, Andrew Fergus, Yongsheng Huang, Paul Richardson, William L. Trepicchio, Annemiek Broyl, Pieter Sonneveld, John D. Shaughnessy, Jr, P. Leif Bergsagel, David Schenkein, Dixie-Lee Esseltine, Anthony Boral, Kenneth C. Anderson

Blood (2006) 109 (8): 3177–3188.

https://doi.org/10.1182/blood-2006-09-044974

Published: 2006

Includes: Supplemental data

Journal Articles

Gene-expression profiling of Waldenström macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

Wee J. Chng, Roelandt F. Schop, Tammy Price-Troska, Irene Ghobrial, Neil Kay, Diane F. Jelinek, Morie A. Gertz, Angela Dispenzieri, Martha Lacy, Robert A. Kyle, Philip R. Greipp, Renee C. Tschumper, Rafael Fonseca, Peter Leif Bergsagel

Blood (2006) 108 (8): 2755–2763.

https://doi.org/10.1182/blood-2006-02-005488

Published: 2006

Includes: Supplemental data

Journal Articles

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Natalia Gonzalez-Paz, Wee J. Chng, Rebecca F. McClure, Emily Blood, Martin M. Oken, Brian Van Ness, C. David James, Paul J. Kurtin, Kimberly Henderson, Gregory J. Ahmann, Morie Gertz, Martha Lacy, Angela Dispenzieri, Philip R. Greipp, Rafael Fonseca

Blood (2006) 109 (3): 1228–1232.

https://doi.org/10.1182/blood-2006-05-024661

Published: 2006

Journal Articles

Clinical implication of centrosome amplification in plasma cell neoplasm

Wee J. Chng, Greg J. Ahmann, Kim Henderson, Rafael Santana-Davila, Philip R. Greipp, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Shaji Kumar, S. Vincent Rajkumar, John A. Lust, Robert A. Kyle, Steven R. Zeldenrust, Suzanne R. Hayman, Rafael Fonseca

Blood (2006) 107 (9): 3669–3675.

https://doi.org/10.1182/blood-2005-09-3810

Published: 2006

NARROW

Pomalidomide Plus Dexamethasone (Pd) in the Treatment of Asian Patients with Relapsed/Refractory Myeloma (RRMM) Who Are Previously Treated with Bortezomib and Refractory to Lenalidomide - Interim Analysis of a Trial By the Asian Myeloma Network (AMN)

Paediatric-Inspired Acute Lymphoblastic Leukemia Protocols, Are They Too Toxic for Young Adults?

“Micro”-managing the MiRNome in SzS

Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications

The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition

Activation of MYC Pathway Is a Unifying Pathological Event in the Progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma (MM).

Multiple Myeloma (MM) Is Characterized by Genomic Instability Regardless of Ploidy Categories and Degree of Karyotypic Complexity Is an Important Prognostic Factor.

Identification of Survival Critical Genomic Gains or Losses in Myeloma (MM) Using Array-Comparative Genomic Hybridization (aCGH).

Gene Expression Profiling of Pulmonary Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Identifies New Diagnostic Markers, Biological Heterogeneity and Therapeutic Targets.

Survival of genetic subtypes of relapsed myeloma may be modulated by secondary events

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

Gene-expression profiling of Waldenström macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Clinical implication of centrosome amplification in plasma cell neoplasm

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only